Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Short term Debt (2016 - 2026)

SANUWAVE Health has reported Short term Debt over the past 13 years, most recently at $5.6 million for Q1 2026.

  • Quarterly Short term Debt fell 78.55% to $5.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Mar 2026, down 78.55% year-over-year, with the annual reading at $5.6 million for FY2025, N/A changed from the prior year.
  • Short term Debt was $5.6 million for Q1 2026 at SANUWAVE Health, down from $5.6 million in the prior quarter.
  • Over five years, Short term Debt peaked at $26.8 million in Q2 2025 and troughed at $5.6 million in Q1 2026.
  • The 5-year median for Short term Debt is $16.1 million (2023), against an average of $16.6 million.
  • Year-over-year, Short term Debt surged 45.28% in 2024 and then crashed 78.55% in 2026.
  • A 5-year view of Short term Debt shows it stood at $14.4 million in 2022, then rose by 26.79% to $18.3 million in 2023, then surged by 33.64% to $24.4 million in 2024, then crashed by 76.92% to $5.6 million in 2025, then decreased by 0.94% to $5.6 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Short term Debt are $5.6 million (Q1 2026), $5.6 million (Q4 2025), and $26.8 million (Q2 2025).